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The fruit fly Drosophila melanogaster has been used extensively to model the effects of both loss of fly TDP-43 (dTDP-43), encoded by the gene TBPH, and overexpression of dTDP-43 or human TDP-43 in the fly (reviewed in [5] ). Wellcharacterized driver lines have allowed for TDP-43 levels to be altered within specific, restricted types of cells. Several models of neurodegeneration have been developed with overexpression of disease proteins in the fly eye, given the ease of observing its structural degenerative phenotypes. Many studies have shown that overexpression of human TDP-43 in the fly eye results in an age-and dosedependent degeneration [5] . Reduction or overexpression of dTDP-43 in all fly neurons or within larval or adult motor neurons, the relevant cell type for ALS patients, results in decreased locomotion and adult lifespan [5] . Several groups have reported disrupted synaptic morphology and defective synaptic transmission when TDP-43 levels are altered strictly within motor neurons, suggesting that endogenous TDP-43 may function to regulate synaptic physiology [5] .
The fruit fly has been an experimental workhorse for groundbreaking studies over the last century in both genetics and neurobiology [6] . Naturally, the development of so many different fly TDP-43 models has facilitated several genetic modifier screens. Microarrays, for example, have been employed for the unbiased detection of gene expression changes caused by TDP-43 overexpression in the fly eye or in all neurons. This approach led Zhan et al. to find that decreased Notch signaling or loss-of-function of fly nucleoporin Nup50 could increase the lifespan of transgenic TDP-43 flies [7] . Tibbetts and colleagues also used lifespan as a read-out to perform a genetic screen for TDP-43 overexpression-induced motor neuron toxicity. They performed the screen using a collection of flies deficient for small segments of each chromosome, finding loss-of-function of wnd, the fly MAP3 kinase wallenda, extends the lifespan of TDP-43 flies [8] . Further experiments demonstrated that upregulation of TDP-43 in motor neurons causes oxidative stress, and the activation of innate immunity genes and manipulating genes within these pathways was sufficient to modulate TDP-43 toxicity [8] .
These unbiased genetic screening approaches have illuminated potential mechanisms of neuronal toxicity associated with TDP-43, but have largely relied on lifespan as a read-out for modulation of toxicity, even in models when TDP-43 expression is restricted to motor neurons. This gross reduction in lifespan has made it difficult to study genes that can modulate the changes in synaptic morphology and function associated with TDP-43 overexpression in adult flies. In this issue, Sreedharan et al. describe a new fly model of TDP-43 toxicity that resolves some of the limitations of previous models [4] . Their model is novel in its ability to allow for single motor neurons expressing TDP-43 to be monitored morphologically for degeneration along with their accompanying neuromuscular junctions over several weeks in an otherwise healthy fly (Figure 1 ). This task was accomplished through the use of the mosaic analysis with a repressible cell marker (MARCM) system [9] . Freeman and colleagues recently modified this tool by incorporating genetically encoded flippase (FLP) sources that drive mitotic recombination very early in neuronal lineages, thereby facilitating high throughput screening. When combined with GAL4 driver lines, transgene expression can be limited to MARCM clones within very few neurons of a subtype. This allowed them to discriminate the morphology of single axons in the fly wing in an assay for injuryinduced axonal degeneration [10] . Here, they report a similar MARCM approach that allows for the expression of human TDP-43 in only a few motor or sensory neurons in the fly leg [4] . Axons and neuromuscular junctions can also be marked by expression of membranetethered CD8-GFP, which was used to score TDP-43-associated neurodegeneration.
Sreedharan et al. found that expression of both wild-type TDP-43 and the ALSlinked mutant protein Q331K was particularly toxic to motor neurons over four weeks, with disruption of synaptic morphology and loss of axonal integrity in a 'dying back' fashion [4] . Directing expression of their transgene to motor neurons of the fly leg along with the membrane-tethered GFP facilitated microscopic preparation and analysis and the ability to rapidly perform a mutagenesis screen to identify genetic modifiers of TDP-43 toxicity.
First, they used genetic manipulations to demonstrate that TDP-43 motor neuron degeneration is distinct from Sarm1-mediated active Wallerian degeneration [4] , a process that may occur in ALS patient neurons [11] . Interestingly, this finding appears to be in contrast with a recent report in Caenorhabditis elegans describing that TIR-1, the nematode Sarm1 ortholog, acts downstream of TDP-43 toxicity in neurons (although this may not be a cell autonomous effect) [12] , and the finding that fly Wallenda, a potential Wallerian degeneration regulator [13] , can modify TDP-43 toxicity [8] .
The authors then used the chemical ethyl methanesulfonate (EMS) to generate random mutations throughout the genome and they focused on the X chromosome to look for homozygous mutations that could suppress TDP-43 motor neuron toxicity in MARCM axons (Figure 1 ). They manually screened over 3,000 mutant lines under the microscope and discovered five mutants that strongly suppressed TDP-43 toxicity. Three of these were mutations in the same gene and the other two were unique, resulting in the final identification of three distinct genes that suppress TDP-43 toxicity when mutated [4] . One suppressor was shaggy (sgg), the fly homolog of glycogen synthase kinase-3, a known modifier of neurodegenerative disease processes [14] . Next, in three distinct mutant lines, was a previously uncharacterized gene they named hat-trick, because of its similarity to the human heterochromatinassociating proteins ARID4A/B and its influence on TDP-43 toxicity (and perhaps because this gene scored three times in their screen). Last, the strongest suppressor of TDP-43 mapped to the gene xmas-2, a gene encoding a component of a protein complex involved in mRNA export.
While this study has uncovered three novel and potent modifiers of TDP-43 motor neuron toxicity, further mechanistic work remains for future study. Mutations in sgg did not alter TDP-43 protein levels, whereas mutations in hat-trick and xmas-2 both reduced TDP-43 protein expression and hint at possible posttranscriptional effects specific to TDP-43.
Excitingly, future TDP-43 modifiers await discovery, as the genetic screen described here covered the X chromosome, leaving 80% of the fly genome yet to be screened. Furthermore, this powerful fly leg motor neuron screening platform described by Sreedharan et al. can now be harnessed to model the toxicity associated with a multitude of other neurodegenerative disease proteins in vivo in adult flies and, in a larger context, to study genes that are essential for motor neuron function and survival.
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Opposing roles of p38 and JNK in a Drosophila A schematic of the MARCM strategy that was employed to achieve restricted expression of transgenes in very few motor neurons in the fly leg. Flies are created that have motor neuron-specific expression of the transcription factor Gal4, membrane-tethered CD8-GFP and mutant TDP-43 under the control of Gal4-responsive UAS elements, and X chromosomes harboring FRT sites. One X chromosome carries an EMS-induced mutation in a random gene and the other expresses Gal80, a transcriptional regulator that inhibits transcriptional activation by Gal4. Nearly every motor neuron in the fly will not express the TDP-43 and GFP transgenes due to the inhibition of Gal4 by Gal80. However, during development some of the motor neuron progenitor cells will express flp recombinase under the ase promoter. Flp will recombine the X chromosomes at the FRT sites in these progenitors and when they undergo mitosis to become adult motor neurons some of these neurons will lose the Gal80 transgene, releasing the inhibition of Gal4, which turns on the UAS-dependent transcription of mutant TDP-43 and the membrane-tethered GFP to label axons and neuromuscular junctions (NMJs). These GFP-labeled neurons will also be homozygous for the EMS-induced mutation, allowing these genes to be tested as potential loss-of-function suppressors of TDP-43 toxicity. In the future this genetic screening approach could be applied broadly to discover more modifiers of TDP-43 on other fly chromosomes and also extended to the study of other neurodegenerative disease genes, such as FUS/TLS and C9orf72 in ALS, a-synuclein in Parkinson disease, mutant huntingtin in Huntington disease, and tau and Ab in Alzheimer disease.
